1 |
Berciano J, Garcia A, Gallardo E, Peeters K, Pelayo-Negro AL, Alvarez-Paradelo S, et al. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review. J Neurol. 2017;264:1655-1677. https://doi.org/10.1007/s00415-017-8474-3
DOI
|
2 |
Latour P, Gonnaud PM, Ollagnon E, Chan V, Perelman S, Stojkovic T, et al. Simple mutation analysis in dominant demyelinating Charcot-Marie-Tooth disease three novel mutations. J Peripher Nerv Syst. 2006;11:148-155. https://doi.org/10.1111/j.1085-9489.2006.00080.x
DOI
|
3 |
Jeng LJ, Balice-Gordon RJ, Messing A, Fischbeck KH, Scherer SS. The effects of a dominant connexin32 mutant in myelinating Schwann cells. Mol Cell Neurosci. 2006;32:283-298. https://doi.org/10.1016/j.mcn.2006.05.001
DOI
|
4 |
Kim SB, Park KD, Choi BO. Diagnosis and treatment in Charcot-Marie-Tooth disease. Ann Clin Neurophysiol. 2005;7: 65-74.
|
5 |
Pareyson D, Scaioli V. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med. 2006;8: 3-22. https://doi.org/10.1385/nmm:8:1-2:3
DOI
|
6 |
Stanton M, Pannoni V, Lewis RA, Logigian EL, Naguib D, Shy ME, et al. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2006;34:417-422. https://doi.org/10.1002/mus.20600
DOI
|
7 |
Lehmann HC, Burke D, Kuwabara S. Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2019;90:981-987. https://doi.org/10.1136/jnnp-2019-320314
DOI
|
8 |
Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, van Doorn PA. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 2019;18:784-794. https://doi.org/10.1016/S1474-4422(19)30144-9
DOI
|
9 |
Escorcio-Bezerra ML, Pinto WBVR, Bichuetti DB, Souza PVS, Nunes RM, Silva LHL, et al. Immune-mediated inflammatory polyneuropathy overlapping Charcot-Marie-Tooth 1B. J Clin Neurosci. 2020;75:228-231. https://doi.org/10.1016/j.jocn.2020.03.014
DOI
|
10 |
Kang JH, Lee YS. Sensory nerve conduction studies in the diagnosis of diabetic sensorimotor polyneuropathy: electrophysiological features. J Phys Ther Sci. 2012;24:139-142.
DOI
|
11 |
Staudt M, Diederich JM, Meisel C, Meisel A, Klehmet J. Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP. BMC Neurol. 2017;17:81. https://doi.org/10.1186/s12883-017-0860-z
DOI
|
12 |
Garg N, Howells J, Yiannikas C, Vucic S, Krishnan AV, Spies J, et al. Motor unit remodelling in multifocal motor neuropathy: The importance of axonal loss. Clin Neurophysiol. 2017;128:2022-2028. https://doi.org/10.1016/j.clinph.2017.07.414
DOI
|
13 |
Stino AM, Naddaf E, Dyck PJ, Dyck PJB. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach. Muscle Nerve. 2021;63:157-169. https://doi.org/10.1002/mus.27046
DOI
|
14 |
Kuwabara S, Misawa S. Chronic inflammatory demyelinating polyneuropathy. Adv Exp Med Biol. 2019;1190:333-343. https://doi.org/10.1007/978-981-32-9636-7_21
DOI
|
15 |
Oh SJ. Clinical electromyography. Nerve conduction studies, third edition. Philadelphia: Lippincott Williams & Wilkins, 2003;86-135.
|
16 |
Mary MR. Axonal charcot-Marie-Tooth disease. Neurology. 2005; 65:186-187. https://doi.org/10.1212/01.wnl.0000173904.97549.94
DOI
|
17 |
Harding AE, Thomas PK. Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet. 1980; 17:329-336. https://doi.org/10.1136/jmg.17.5.329
DOI
|
18 |
Manganelli F, Pisciotta C, Reilly MM, Tozza S, Schenone A, et al. Nerve conduction velocity in CMT1A: what else can we tell?. Eur J Neurol. 2016;23:1566-1571.
DOI
|
19 |
Kang JH, Kim HJ, Lee ER. Electrophysiological evaluation of chronic inflammatory demyelinating polyneuropathy and charcot-marie-tooth type 1: dispersion and correlation analysis. J Phys Ther Sci. 2013;25:1265-1268. https://doi.org/10.1589/jpts.25.1265
DOI
|